Is disclosure of potential conflicts of interest in medicine and public health sufficient to increase transparency and decrease corruption?
about
Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic reviewChronological changes in Japanese physicians' attitude and behavior concerning relationships with pharmaceutical representatives: a qualitative study.Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics.Industry support of physician education in the USA.
P2860
Is disclosure of potential conflicts of interest in medicine and public health sufficient to increase transparency and decrease corruption?
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Is disclosure of potential con ...... rency and decrease corruption?
@en
Is disclosure of potential con ...... rency and decrease corruption?
@nl
type
label
Is disclosure of potential con ...... rency and decrease corruption?
@en
Is disclosure of potential con ...... rency and decrease corruption?
@nl
prefLabel
Is disclosure of potential con ...... rency and decrease corruption?
@en
Is disclosure of potential con ...... rency and decrease corruption?
@nl
P2093
P356
P1476
Is disclosure of potential con ...... rency and decrease corruption?
@en
P2093
Angela Spelsberg
Anke Martiny
P S Schoenhoefer
Working Group on Health of Transparency International, German Chapter
P304
P356
10.1136/JECH.2008.084939
P577
2009-08-01T00:00:00Z